Enterprise Value

31.36M

Cash

3.529M

Avg Qtr Burn

-1.127M

Short % of Float

0.18%

Insider Ownership

25.66%

Institutional Own.

4.27%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Ketamir-2 Details
Treatment Resistant Depression, Major depressive disorder, Acute Suicidal Ideation and Behavior, Post-traumatic stress disorder, Mental health

IND

Submission